OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that Richard Slansky, OncoSec's Chief Financial...

PATTERSON-UTI ENERGY, INC. (NASDAQ: PTEN) today announced that it will make a presentation on December 7, 2016 at the Cowen and Company Energy & Natural Resources Conference. Representing the...

Shionogi & Co., Ltd. (hereafter "Shionogi") presented additional clinical data from a Phase 2 proof-of-concept study for S-033188, a cap-dependent endonuclease inhibitor targeting influenza. The...

The Group observes 90 years since founding and 20 years of exhibiting at conference Introduces “One Guerbet” exhibit Princeton, NJ, November 30, 2016 – Guerbet (FR0000032526 GBT), the global...

Over the past two days, Puerto Rico was the hub for life sciences activity at Biolatam® 2016, in which more than 250 leaders from the biotech, pharmaceutical and technology industry came together...